Westlake Chemical (NYSE:WLK) reported Q4 EPS of $1.79, $0.49 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.37 billion.
Westlake Chemical (NYSE:WLK) reported Q4 EPS of $1.79, $0.49 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.37 billion.